Cutaneous Manifestations of Rheumatologic Disease

Table of Contents

Rheumatologic diseases, such as lupus, rheumatoid arthritis, and scleroderma, are often associated with various skin manifestations. These cutaneous symptoms can be a presenting feature of the underlying disease, and may also serve as an important clue in the diagnosis and management of rheumatologic conditions.

Dr. Ruth Ann Vleugels, a leading expert in dermatology and rheumatology, will be discussing the cutaneous manifestations of rheumatologic disease at CCR West in San Diego on September 7th – 10th, 2023. Dr. Vleugels, who holds an MPH and an MBA in addition to her medical degree, is an Associate Professor of Dermatology at Harvard Medical School, and Director of the Connective Tissue Disease Clinic and the Autoimmune Skin Disease Program at Brigham and Women’s Hospital.

Cutaneous manifestations of rheumatologic disease can take many forms, and may involve the skin, hair, nails, and mucous membranes. Some of the most common skin findings in rheumatologic disease include photosensitivity, malar rash (butterfly rash), discoid rash, Raynaud’s phenomenon, subcutaneous nodules, and livedo reticularis. These symptoms may also be accompanied by joint pain and swelling, fevers, fatigue, and weight loss.

In addition to helping with diagnosis, recognizing cutaneous manifestations of rheumatologic disease is important for guiding treatment decisions. For example, some medications commonly used to treat rheumatologic disease, such as hydroxychloroquine, can cause skin changes. In some cases, the presence of certain skin findings may suggest a greater risk for internal organ involvement or more severe disease.

Dr. Vleugels’ talk at CCR West will provide attendees with a comprehensive overview of the cutaneous manifestations of rheumatologic disease, as well as the latest advances in diagnosis and treatment. The presentation will cover a broad range of topics, from the clinical presentation and histopathology of skin findings in rheumatologic disease to the use of biologic therapies for skin involvement.

In summary, the cutaneous manifestations of rheumatologic disease are an important aspect of these conditions that dermatologists and rheumatologists should be familiar with. Dr. Vleugels’ upcoming talk at CCR West in San Diego will be a valuable opportunity to learn more about these skin findings and their clinical implications. With her extensive experience and expertise, Dr. Vleugels is sure to provide attendees with a wealth of information and insights into this important topic.